Applied Clinical Trials September 2024 Issue (PDF)
Aligning Technology and Oversight
A New Regulatory Road in Clinical Trials: Digital Twins
Bridging Patient Support Gaps While Navigating Global Regulations
Regulatory CMC: Enhancing Biologics Development
In Focus: Top Takeaways from FDA Final Guidance on Real-World Evidence
The Relationship Between Participant Diversity and DCT Use in Clinical Trials
Driving Inclusion in Clinical Trials: Less Talk, More Trust
Risk Planning: A Review of Industry Trends
Prioritizing People: Why ‘I-Frame’ Interventions are Key to Trial Success
An Overview of FDA Diversity-Related Documents for Clinical Trials
